|
|
|
|
| TRADING CENTER |
41.53+0.06 / +0.14%
GlaxoSmithKline PLC (NYSE:GSK)
41.34-0.19 / -0.46
After hours quote
Prev. Close:
41.47
Open:
40.95
High:
41.56
Low:
40.94
Volume:
1,164,200
Volume Avg.:
1,538,000
52wk Range:
27.15 - 42.18
Market Cap (mil):
107,751.35
P/E Ratio:
12.74
Dividend Yield:
N/A
| Biogen's Rituxan Label Expansion Delayed - Analyst Blog - Zacks.com | |
| 4-Star Stocks Poised to Pop: Merck - MotleyFool.com | |
| EU Panel: Affirm Benefits Of Celvapan, Focetria, Pandemrix - Dow Jones | |
| Trading Review for Vivus Inc. Issued by Beacon Equity - GlobeNewswire | |
| 'Fast Money' Recap: Playing Defense - at TheStreet.com | |
| Pfizer Dodges a Bullet - MotleyFool.com | |
| US panel backs new claim for Pfizer lung drug - Reuters | |
| Panel Backing for Prevnar 13 - Analyst Blog - Zacks.com | |
| Why You Can't Afford to Miss These Stocks - MotleyFool.com | |
| Trading Overview for Sinobiopharma Inc. Issued by StockPreacher.com - GlobeNewswire | |
| The Government Won't Be There for You - MotleyFool.com | |
| VIVUS Gets a Spark - MotleyFool.com | |
| U.S. Sees Low Demand for BioCryst Flu Drug - at TheStreet.com | |
| Drugmakers' Differences: Analyst's Toolkit - at TheStreet.com | |
| Anti-Smoking Vaccine from Glaxo - Analyst Blog - Zacks.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 62.31 | -0.12 / -0.19% | 13.60 |
| PFE | Pfizer Inc | 18.36 | 0.25 / 1.38% | 15.43 |
| NVS | Novartis AG | 53.13 | -0.16 / -0.30% | 14.92 |
Short Interest Date:
Oct 30 2009
Short Interest Shares:
4,675,422
Short Interest Ratio:
3.1
Float:
n/a
Short Interest as a % of Float:
n/a
Average Daily Volume:
1,918,800
Outstanding Shares:
2,830,658,118
GlaxoSmithKline plc is a public limited company, which was incorporated on 6th December 1999 under English law. It is a global healthcare Group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products including vaccines, over-the-counter ... (more)
| 2008 Revenue: | $35.0 B | Headquarters: Brentford, Middlesex, |
| Employees: | 99,003 | CEO: Andrew Witty |
| Net Income: | $6.8 B | Industry: Pharmaceuticals |
| Market Cap: | $117.6 B | Website: www.gsk.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| GSK | 41.53 | +0.06 / +0.14% | 41.47 | 41.56 | 40.94 | Profile Chart News |
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
